Juhani S Koskinen1, Ville Kytö2, Markus Juonala3, Jorma S A Viikari3, Jaakko Nevalainen4, Mika Kähönen5, Terho Lehtimäki6, Nina Hutri-Kähönen7, Tomi Laitinen8, Päivi Tossavainen9, Eero Jokinen10, Costan G Magnussen11, Olli T Raitakari12. 1. Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Division of Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20521, Turku, Finland; Department of Medicine, Satakunta Central Hospital, Sairaalantie 3, 28500, Pori, Finland. Electronic address: jskosk@utu.fi. 2. Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Heart Centre, Turku University Hospital, Hämeentie 11, 20521, Turku, Finland. 3. Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Division of Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20521, Turku, Finland; Department of Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland. 4. Faculty of Social Sciences, University of Tampere, Kalevantie 5, 33100, Tampere, Finland. 5. Department of Clinical Physiology, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Faculty of Medicine and Health Technology, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Finnish Cardiovascular Research Center Tampere, University of Tampere, Kalevantie 4, 33100, Tampere, Finland. 6. Faculty of Medicine and Health Technology, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Finnish Cardiovascular Research Center Tampere, University of Tampere, Kalevantie 4, 33100, Tampere, Finland; Department of Clinical Chemistry, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Fimlab Laboratories, Arvo Ylpön katu 4, 33520, Tampere, Finland. 7. Department of Pediatrics, Tampere University Hospital, Teiskontie 35, 33520, Tampere, Finland. 8. Department of Clinical Physiology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. 9. Department of Pediatrics, Oulu University Hospital, Kajaanintie 50, 90220, Oulu, Finland; PEDEGO Research Unit and Medical Research Center Oulu, University of Oulu, Aapistie 5 A, 90220, Oulu, Finland. 10. Department of Pediatrics, University of Helsinki, Stenbäckinkatu 11, 00290, Helsinki, Finland; Hospital for Children and Adolescents, Helsinki University Hospital, Stenbäckinkatu 9, 00290, Helsinki, Finland. 11. Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart, TAS, 7000, Australia. 12. Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Department of Clinical Physiology and Nuclear Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Centre for Population Health Research, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Abstract
BACKGROUND AND AIMS: Carotid plaque is a specific sign of atherosclerosis and adults with carotid plaque are at increased risk for cardiovascular outcomes. Atherosclerosis has roots in childhood and pediatric guidelines provide cut-off values for cardiovascular risk factors. However, it is unknown whether these cut-offs predict adulthood advanced atherosclerosis. METHODS: The Cardiovascular Risk in Young Finns Study is a follow-up of children that begun in 1980 when 2653 participants with data for the present analyses were aged 3-18 years. In 2001 and 2007 follow-ups, in addition to adulthood cardiovascular risk factors, carotid ultrasound data was collected. Long-term burden, as the area under the curve, was evaluated for childhood (6-18 years) risk factors. To study the associations of guideline-based cut-offs with carotid plaque, both childhood and adult risk factors were classified according to clinical practice guidelines. RESULTS: Carotid plaque, defined as a focal structure of the arterial wall protruding into lumen >50% compared to adjacent intima-media thickness, was present in 88 (3.3%) participants. Relative risk for carotid plaque, when adjusted for age and sex, was 3.03 (95% CI, 1.76-5.21) for childhood dyslipidemia, 1.51 (95% CI, 0.99-2.32) for childhood elevated systolic blood pressure, and 1.93 (95% CI, 1.26-2.94) for childhood smoking. Childhood dyslipidemia and smoking remained independent predictors of carotid plaque in models additionally adjusted for adult risk factors and family history of coronary heart disease. Carotid plaque was present in less than 1% of adults with no childhood risk factors. CONCLUSIONS: Findings reinforce childhood prevention efforts and demonstrate the utility of guideline-based cut-offs in identifying children at increased risk for adulthood atherosclerosis.
BACKGROUND AND AIMS: Carotid plaque is a specific sign of atherosclerosis and adults with carotid plaque are at increased risk for cardiovascular outcomes. Atherosclerosis has roots in childhood and pediatric guidelines provide cut-off values for cardiovascular risk factors. However, it is unknown whether these cut-offs predict adulthood advanced atherosclerosis. METHODS: The Cardiovascular Risk in Young Finns Study is a follow-up of children that begun in 1980 when 2653 participants with data for the present analyses were aged 3-18 years. In 2001 and 2007 follow-ups, in addition to adulthood cardiovascular risk factors, carotid ultrasound data was collected. Long-term burden, as the area under the curve, was evaluated for childhood (6-18 years) risk factors. To study the associations of guideline-based cut-offs with carotid plaque, both childhood and adult risk factors were classified according to clinical practice guidelines. RESULTS: Carotid plaque, defined as a focal structure of the arterial wall protruding into lumen >50% compared to adjacent intima-media thickness, was present in 88 (3.3%) participants. Relative risk for carotid plaque, when adjusted for age and sex, was 3.03 (95% CI, 1.76-5.21) for childhood dyslipidemia, 1.51 (95% CI, 0.99-2.32) for childhood elevated systolic blood pressure, and 1.93 (95% CI, 1.26-2.94) for childhood smoking. Childhood dyslipidemia and smoking remained independent predictors of carotid plaque in models additionally adjusted for adult risk factors and family history of coronary heart disease. Carotid plaque was present in less than 1% of adults with no childhood risk factors. CONCLUSIONS: Findings reinforce childhood prevention efforts and demonstrate the utility of guideline-based cut-offs in identifying children at increased risk for adulthood atherosclerosis.
Authors: Yaxing Meng; Marie-Jeanne Buscot; Markus Juonala; Feitong Wu; Matthew K Armstrong; Brooklyn J Fraser; Katja Pahkala; Nina Hutri-Kähönen; Mika Kähönen; Tomi Laitinen; Jorma S A Viikari; Olli T Raitakari; Costan G Magnussen; James E Sharman Journal: J Am Heart Assoc Date: 2022-06-14 Impact factor: 6.106
Authors: Nouran Y Salah; Dina Abu Zeid; Rania N Sabry; Reham F Fahmy; Mona A El Abd; Eman Awadallah; Azza Omran; Yasmin G El Gendy Journal: Eur J Clin Nutr Date: 2021-04-13 Impact factor: 4.016
Authors: Kylie Karnebeek; Jesse M Rijks; Elke Dorenbos; Willem-Jan M Gerver; Jogchum Plat; Anita C E Vreugdenhil Journal: Nutrients Date: 2020-04-26 Impact factor: 5.717
Authors: Saara Marttila; Leena E Viiri; Pashupati P Mishra; Brigitte Kühnel; Pamela R Matias-Garcia; Leo-Pekka Lyytikäinen; Tiina Ceder; Nina Mononen; Wolfgang Rathmann; Juliane Winkelmann; Annette Peters; Mika Kähönen; Nina Hutri-Kähönen; Markus Juonala; Katriina Aalto-Setälä; Olli Raitakari; Terho Lehtimäki; Melanie Waldenberger; Emma Raitoharju Journal: Clin Epigenetics Date: 2021-07-22 Impact factor: 6.551